Matako, Y.; Suttisingtong, K.; Boonsombat, J.; Sirirak, J.; Limpachayaporn, P. The Synthetic Pathways of a New 1,2,3-Triazole-Containing Sorafenib Analogue and Its Cytotoxicity towards Cancer Cell Lines. rmutsvrj 2021, 13, 244–258.

01 May 2021
0

Matako, Y.; Suttisingtong, K.; Boonsombat, J.; Sirirak, J.; Limpachayaporn, P. The Synthetic Pathways of a New 1,2,3-Triazole-Containing Sorafenib Analogue and Its Cytotoxicity towards Cancer Cell Lines. rmutsvrj 202113, 244–258.

Tags

Share this

Related Posts

Ganihigama, D. U.; Sureram, S.; Sanghe,r S.; Hongmanee, P.; Aree, T.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Antimycobacterial Activity of Natural Products and Synthetic Agents: Pyrrolodiquinolines and Vermelhotin as Anti-Tubercular Leads Against Clinical Multidrug Resistant Isolates of Mycobacterium tuberculosis. Eur. J. Med. Chem. 2015, 89, 1-12.

Recent Posts